Effects of chemotherapy on endogenous erythropoietin levels and the pharmacokinetics and erythropoietic response of darbepoetin alfa: A randomised clinical trial of synchronous versus asynchronous dosing of darbepoetin alfa-Reference-Cited by-同舟云学术

Effects of chemotherapy on endogenous erythropoietin levels and the pharmacokinetics and erythropoietic response of darbepoetin alfa: A randomised clinical trial of synchronous versus asynchronous dosing of darbepoetin alfa

Published:2005-05 Issue:8 Volume:41 Page:1140-1149
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Glaspy John,Henry David,Patel Ravi,Tchekmedyian Simon,Applebaum Steve,Berdeaux Donald,Lloyd Richard,Berg Russell,Austin Matt,Rossi Greg

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference44 articles.

1. Chemotherapy-induced anemia in adults: incidence and treatment;Groopman;J Natl Cancer Inst,1999

2. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing;Gabrilove;J Clin Oncol,2001

3. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial;Littlewood;J Clin Oncol,2001

4. Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia;Mirtsching;Oncology,2002

5. Assessment of hematologic effects and fatigue in cancer patients with chemotherapy-induced anemia given darbepoetin alfa every two weeks;Vadhan-Raj;J Support Oncol,2003

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic Growth Factors;Pharmaceutical Biotechnology;2024

2. Management of anemia in patients with cancer: 2019 Italian Association of Medical Oncology (AIOM) guidelines;Tumori Journal;2020-06-02

3. Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience;Advances in Chronic Kidney Disease;2019-07

4. Hematopoietic Growth Factors;Pharmaceutical Biotechnology;2019

5. Comparison of the Pharmacokinetic–Pharmacodynamic Relationships of Two Darbepoetin Alfa Formulations in Healthy Male Volunteers;BioDrugs;2018-12-01